Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer
Version of Record online: 17 FEB 2011
© 2011 Japanese Cancer Association
Volume 102, Issue 4, pages 762–768, April 2011
How to Cite
Wunderlich, A., Fischer, M., Schloßhauer, T., Ramaswamy, A., Greene, B. H., Brendel, C., Doll, D., Bartsch, D. and Hoffmann, S. (2011), Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer. Cancer Science, 102: 762–768. doi: 10.1111/j.1349-7006.2011.01853.x
- Issue online: 18 MAR 2011
- Version of Record online: 17 FEB 2011
- Accepted manuscript online: 8 JAN 2011 09:51AM EST
- (Received September 1, 2010/Revised December 16, 2010/Accepted December 20, 2010/Accepted manuscript online January 8, 2011)
Data S1. Appendix to the methods of western blotting.
Data S2. Appendix to the methods of immunohistochemistry.
|CAS_1853_sm_DataS1-DataS2.doc||25K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.